22.22
Schlusskurs vom Vortag:
$21.48
Offen:
$21.9
24-Stunden-Volumen:
206.46K
Relative Volume:
0.83
Marktkapitalisierung:
$570.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$11.77M
KGV:
38.41
EPS:
0.5785
Netto-Cashflow:
$-19.23M
1W Leistung:
+1.28%
1M Leistung:
+23.58%
6M Leistung:
+69.75%
1J Leistung:
+54.95%
Tourmaline Bio Inc Stock (TRML) Company Profile
Firmenname
Tourmaline Bio Inc
Sektor
Branche
Telefon
646-481-9832
Adresse
27 WEST 24TH STREET, NEW YORK
Vergleichen Sie TRML mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TRML
Tourmaline Bio Inc
|
22.22 | 551.79M | 0 | 11.77M | -19.23M | 0.5785 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-23 | Eingeleitet | Chardan Capital Markets | Buy |
2025-03-06 | Eingeleitet | Wedbush | Outperform |
2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
2024-11-11 | Bestätigt | H.C. Wainwright | Buy |
2023-12-15 | Eingeleitet | Jefferies | Buy |
2023-12-04 | Fortgesetzt | H.C. Wainwright | Buy |
2023-11-17 | Eingeleitet | Truist | Buy |
2023-10-31 | Eingeleitet | Guggenheim | Buy |
2023-10-25 | Eingeleitet | Piper Sandler | Overweight |
2022-10-20 | Eingeleitet | H.C. Wainwright | Buy |
2022-07-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
Tourmaline Bio Inc. Shows Early Signs of Technical StrengthPortfolio Update Report & Weekly High Conviction Ideas - 선데이타임즈
Will a bounce in Tourmaline Bio Inc. offer an exitDay Trade & Smart Allocation Stock Reports - Newser
Tourmaline Bio, Inc. SEC 10-Q Report - TradingView
Tourmaline Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tourmaline Bio Reports Loss as R&D Rises - Nasdaq
Tourmaline Bio Inc. Reversal Rally May Surprise BearsWeekly Profit Summary & Daily Growth Stock Investment Tips - beatles.ru
Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Bluefield Daily Telegraph
Is Tourmaline Bio Inc. trending in predictive chart models2025 Retail Activity & Real-Time Volume Analysis - Newser
Is Tourmaline Bio Inc. stock entering bullish territoryRecession Risk & Safe Capital Investment Plans - Newser
Is Tourmaline Bio Inc. trending in predictive chart models [Buy Signal]Free Real-Time Volume Spike Alerts - Newser
Building trade automation scripts for Tourmaline Bio Inc.July 2025 Closing Moves & AI Powered Buy/Sell Recommendations - Newser
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Comparing Tourmaline Bio Inc. in custom built stock radars [Portfolio Update Summary] - Newser
How high can Tourmaline Bio Inc. stock goFree Profit Target Stock Opportunity Monitor - Newser
What makes Tourmaline Bio Inc. stock price move sharply2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
How Tourmaline Bio Inc. stock performs during market volatilityHigh Return Idea With Technical Filter - Newser
Reversal indicators forming on Tourmaline Bio Inc. stockFree Community Entry Consensus Trade Ideas - Newser
How to track smart money flows in Tourmaline Bio Inc.Free Daily Momentum Screener With Alerts - Newser
Why Tourmaline Bio Inc. stock attracts strong analyst attentionWeekly Stock Market Strategy Summary - Newser
Tourmaline Bio Inc. stock chart pattern explainedTrading Volume Anomaly Summary and Insight - Newser
Is Tourmaline Bio Inc. stock ready for a breakoutLow-Risk Reversal Pattern Analysis Tracker - Newser
New Product Launches: Will They Boost Tourmaline Bio Inc. Stock in 2025Buy and Hold Strategy for Capital Safety - Newser
Will Tourmaline Bio Inc. continue its uptrendOversold Stock Bounce Playbook Generator - Newser
Published on: 2025-08-08 22:37:48 - Newser
Analyzing Tourmaline Bio Inc. with multi timeframe chartsQuarterly Investment Outlook and Key Summary - Newser
What to do if you’re stuck in Tourmaline Bio Inc.Neural Model for Stock Price Movement - Newser
Will Tourmaline Bio Inc. stock recover after recent dropTechnical Chart Summary for Momentum Stocks - Newser
Is Tourmaline Bio Inc. forming a reversal patternFree Market Momentum and Signal Alerts - Newser
Is Tourmaline Bio Inc. stock a good hedge against inflationTechnical Chart Summary for Momentum Stocks - Newser
Tourmaline Bio (TRML) Expected to Announce Earnings on Thursday - Defense World
Can momentum traders help lift Tourmaline Bio Inc.Free Safe Entry Stock Watch Suggestions - Newser
Tourmaline Bio (NASDAQ:TRML) Is In A Good Position To Deliver On Growth Plans - 富途牛牛
Tourmaline Bio Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
When is Tourmaline Bio Inc. stock expected to show significant growthPhenomenal capital gains - Jammu Links News
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):